Susquehanna International Group’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-309
Closed -$57.6K 12804
2025
Q3
$57.6K Buy
309
+32
+12% +$8.05K ﹤0.01% 11815
2025
Q2
$69.4K Buy
+277
New +$84.6K ﹤0.01% 11992
2022
Q4
Sell
-1
Closed -$56.5K 12876
2022
Q3
$83K Hold
1
﹤0.01% 11849
2022
Q2
$56K Buy
+1
New +$70.4K ﹤0.01% 11917
2022
Q1
Sell
-3
Closed -$293K 13373
2021
Q4
$152K Sell
3
-1
-25% -$83.4K ﹤0.01% 11776
2021
Q3
$524K Hold
4
﹤0.01% 9265
2021
Q2
$631K Sell
4
-3
-43% -$492K ﹤0.01% 8996
2021
Q1
$1.42M Buy
7
+1
+17% +$220K ﹤0.01% 6800
2020
Q4
$1.15M Sell
6
-2
-25% -$309K ﹤0.01% 6390
2020
Q3
$1.14M Buy
8
+1
+14% +$158K ﹤0.01% 5781
2020
Q2
$1M Buy
7
+5
+250% +$611K ﹤0.01% 5913
2020
Q1
$207K Buy
+2
New +$206K ﹤0.01% 8619

Other funds holding GNPX

Susquehanna International Group's GNPX Position: Q4 2025 in Review

Susquehanna International Group sold out of Genprex (GNPX) in Q4 2025, closing a stake of 309 shares — an estimated $57.6K sold.

Susquehanna International Group first reported a position in GNPX in Q1 2020 and held it in 12 quarters. The position peaked at $1.42M in Q1 2021. 9 funds tracked by Wall St. Rank hold GNPX as of Q4 2025.

  • Susquehanna International Group reported no remaining Genprex position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 309 Genprex shares in Q4 2025, an estimated $57.6K.
  • Susquehanna International Group first reported a position in Genprex in Q1 2020 and held it in 12 quarters.
  • Susquehanna International Group's Genprex position peaked at $1.42M in Q1 2021.
  • 9 funds tracked by Wall St. Rank held Genprex as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.